Figure 6
From: Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis
The promoter methylation level of SLC35A3 in colorectal cancer tissues and adjacent normal tissues. UALCAN tool was used to analyze the promoter methylation level of SLC35A3 gene in colon cancer and its adjacent normal tissues (A) and rectal cancer and its adjacent normal tissues (B).
